Related Party Transactions (Details Narrative) - USD ($)
|
|
|
|
|
|
|
|
6 Months Ended |
|
Feb. 12, 2026 |
Feb. 10, 2025 |
Oct. 04, 2024 |
Apr. 15, 2024 |
Apr. 05, 2024 |
Apr. 03, 2023 |
Apr. 13, 2022 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Common stock, shares outstanding |
|
|
|
|
|
|
|
32,622,884
|
|
28,682,844
|
| Acquired laboratory equipment |
|
|
|
|
|
|
|
$ 1,392,000
|
$ 656,000
|
|
| Financing lease payments to third-party |
|
|
|
|
|
|
|
295,000
|
$ 212,000
|
|
| Finance lease, liability |
|
|
|
|
|
|
|
$ 766,000
|
|
$ 1,060,000
|
| Purchase price of common stock value |
|
|
|
|
$ 3,500,000
|
|
|
|
|
|
| Percentage of shares issued and outstanding |
|
|
|
|
9.99%
|
|
|
|
|
|
| Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Warrant exercise price |
|
|
|
|
|
|
|
$ 109.2
|
|
|
| Pre-Funded Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase shares |
1,043,478
|
|
|
|
|
|
|
|
|
|
| Warrant exercised |
|
|
|
|
|
|
|
0
|
|
|
| Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Issuance of shares |
|
|
|
|
|
|
|
3,482,000
|
11,146,000
|
|
| Warrants to purchase shares |
|
3,069,926
|
|
342,888
|
|
|
|
|
|
|
| Private Placement [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Sale of stock, shares |
|
109,756
|
|
42,373
|
|
|
|
|
|
|
| Proceeds from private placement |
$ 26,000,000
|
$ 29,100,000
|
|
|
|
|
|
|
|
|
| Sale of stock price per share |
|
$ 2.05
|
|
$ 2.95
|
|
|
|
|
|
|
| Bio Rad Laboratories Inc [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Royalty expense |
|
|
|
|
|
|
|
$ 1,000
|
|
|
| Accounts payable and accruals due |
|
|
|
|
|
|
|
$ 2,000,000
|
|
$ 2,800,000
|
| Broadwood Capital LP [Member] | Underwritten Offering [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Warrant exercise price |
|
|
|
|
|
|
$ 30.6
|
|
|
|
| Warrant to purchase common stock |
|
|
|
|
|
|
300,187
|
|
|
|
| Broadwood Capital LP [Member] | Underwritten Offering [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Sale of stock, shares |
|
|
|
|
|
|
143,292
|
|
|
|
| Broadwood Capital LP [Member] | Underwritten Offering [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Sale of stock, shares |
|
|
|
|
|
|
261,032
|
|
|
|
| Broadwood Capital LP [Member] | Underwriters [Member] | Underwritten Offering [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Warrant to purchase common stock |
|
|
|
|
|
|
39,154
|
|
|
|
| Pura Vida Investments LLC [Member] | Underwritten Offering [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Warrant to purchase common stock |
|
|
|
|
|
|
286,585
|
|
|
|
| Pura Vida Investments LLC [Member] | Underwritten Offering [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Warrant to purchase common stock |
|
|
|
|
|
|
150,093
|
|
|
|
| Pura Vida Investments LLC [Member] | Underwritten Offering [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Sale of stock, shares |
|
|
|
|
|
|
249,204
|
|
|
|
| Issuance of shares |
|
|
|
|
|
|
286,585
|
|
|
|
| Pura Vida Investments LLC [Member] | Underwriters [Member] | Underwritten Offering [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Issuance of shares |
|
|
|
|
|
|
37,380
|
|
|
|
| AWM [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Warrant to purchase common stock |
|
|
|
|
|
|
187,617
|
|
|
|
| Securities Purchase Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Proceeds from private placement |
|
|
$ 10,200,000
|
|
|
|
|
|
|
|
| Securities Purchase Agreement [Member] | Pre-Funded Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Number of shares issued |
1,043,478
|
3,069,926
|
|
342,888
|
|
|
|
|
|
|
| Common stock shares issued |
$ 6,000,000
|
$ 10,500,000
|
|
$ 2,000,000
|
|
|
|
|
|
|
| Warrant exercise price |
$ 0.0001
|
$ 0.0001
|
|
|
|
|
|
|
|
|
| Warrant to purchase common stock |
1,043,478
|
|
|
|
|
|
|
|
|
|
| Warrants to purchase shares |
|
3,069,926
|
|
|
|
|
|
|
|
|
| Share price |
$ 5.7499
|
$ 2.05
|
|
$ 2.9163
|
|
|
|
|
|
|
| Warrant unexercised |
|
|
|
|
|
|
|
720,420
|
|
|
| Securities Purchase Agreement [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Number of shares issued |
3,482,498
|
7,536,706
|
|
5,076,900
|
|
2,274,709
|
|
|
|
|
| Offering price to investors |
|
|
|
|
|
$ 6.03
|
|
|
|
|
| Offering price to Insiders |
|
|
|
|
|
$ 7.08
|
|
|
|
|
| Sale of stock, shares |
|
3,609,755
|
|
|
|
|
|
|
|
|
| Related party transaction, description |
|
|
|
to purchase 342,888 shares of its common stock. The purchase price for one share of common stock was $2.9164, and the purchase price for one pre-funded warrant was $2.9163. Insiders subscribed for 42,373 of the shares of common stock sold in the private placement, at a purchase price of $2.95 per share of common stock, which amount reflected the final closing price of the common stock on Nasdaq on the last trading day immediately prior to pricing. Broadwood purchased 2,420,000 shares of common stock for $7,057,688, entities affiliated with AWM purchased 342,889 shares of common stock and 342,888 pre-funded warrants for $2,000,000, and Bio-Rad purchased 1,200,109 shares of common stock for $3,499,998 (see “Bio-Rad Transactions” below). Mr. Arno purchased 33,898 shares of common stock for $100,000. As of June 30, 2026, none of the April 2024 pre-funded warrants have been exercised.
|
|
(i) $6.03 to investors who are not considered to be “insiders” of the Company pursuant to Nasdaq Listing Rules (“Insiders”), which amount reflected the average closing price of our common stock on Nasdaq during the five trading day period immediately prior to pricing, and (ii) $7.08 to Insiders, which amount reflected the final closing price of our common stock on Nasdaq on the last trading day immediately prior to pricing.
|
|
|
|
|
| Warrants to purchase shares |
|
|
|
342,888
|
|
|
|
|
|
|
| Share price |
$ 5.75
|
$ 2.05
|
$ 2.948
|
$ 2.9164
|
|
|
|
|
|
|
| Securities Purchase Agreement [Member] | Common Stock [Member] | Arno [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Number of shares issued |
|
|
|
33,898
|
|
|
|
|
|
|
| Common stock shares issued |
|
|
|
$ 100,000
|
|
$ 150,001
|
|
|
|
|
| Securities Purchase Agreement [Member] | Common Stock [Member] | Patrick W. Smith [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Number of shares issued |
|
1,463,414
|
678,426
|
|
|
|
|
|
|
|
| Common stock shares issued |
|
$ 3,000,000
|
$ 2,000,000
|
|
|
|
|
|
|
|
| Securities Purchase Agreement [Member] | Common Stock [Member] | Unterberg Legacy Capital, LLC [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Number of shares issued |
|
73,169
|
33,921
|
|
|
|
|
|
|
|
| Common stock shares issued |
|
$ 150,000
|
$ 100,000
|
|
|
|
|
|
|
|
| Securities Purchase Agreement [Member] | Common Stock [Member] | James [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Number of shares issued |
|
97,561
|
33,670
|
|
|
|
|
|
|
|
| Common stock shares issued |
|
$ 200,000
|
$ 100,000
|
|
|
|
|
|
|
|
| Securities Purchase Agreement [Member] | Common Stock [Member] | Schutz [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Number of shares issued |
|
12,195
|
3,367
|
|
|
|
|
|
|
|
| Common stock shares issued |
|
$ 25,000
|
$ 10,000
|
|
|
|
|
|
|
|
| Securities Purchase Agreement [Member] | Common Stock [Member] | Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Share price |
|
|
$ 2.97
|
|
|
|
|
|
|
|
| Securities Purchase Agreement [Member] | February 2026 Offering [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Warrant unexercised |
|
|
|
|
|
|
|
720,420
|
|
|
| Securities Purchase Agreement [Member] | February 2026 Offering [Member] | Pre-Funded Warrant [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Warrant exercised |
|
|
|
|
|
|
|
323,058
|
|
|
| Securities Purchase Agreement [Member] | Mr Gutfreund [Member] | Common Stock [Member] | Arno [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Number of shares issued |
|
|
|
|
|
21,162
|
|
|
|
|
| Securities Purchase Agreement [Member] | Bio Rad Laboratories Inc [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Number of shares issued |
439,020
|
1,253,134
|
310,835
|
1,200,109
|
|
|
|
|
|
|
| Common stock shares issued |
$ 2,524,000
|
$ 2,569,000
|
$ 916,000
|
$ 3,499,998
|
|
|
|
|
|
|
| Securities Purchase Agreement [Member] | Broadwood Partners LP [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Common stock, shares outstanding |
|
|
|
|
|
|
|
12,685,041
|
|
|
| Percentage of shares outstanding |
|
|
|
|
|
|
|
39.00%
|
|
|
| Securities Purchase Agreement [Member] | Broadwood Partners LP [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Number of shares issued |
521,739
|
5,165,695
|
1,315,339
|
2,420,000
|
|
1,341,381
|
|
|
|
|
| Common stock shares issued |
$ 3,000,000
|
$ 10,590,000
|
$ 3,878,000
|
$ 7,057,688
|
|
$ 8,093,362
|
|
|
|
|
| Securities Purchase Agreement [Member] | Pura Vida [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Number of shares issued |
|
|
|
|
|
33,150
|
|
|
|
|
| Common stock shares issued |
|
|
|
|
|
$ 200,014
|
|
|
|
|
| Securities Purchase Agreement [Member] | AWM [Member] | Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Number of shares issued |
|
2,052,026
|
275,000
|
342,889
|
|
472,354
|
|
|
|
|
| Common stock shares issued |
|
|
$ 811,000
|
|
|
$ 2,850,000
|
|
|
|
|
| Laboratory Equipment [Member] | Bio Rad Laboratories Inc [Member] |
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
| Acquired laboratory equipment |
|
|
|
|
|
|
|
$ 459,000
|
$ 1.1
|
|
| Laboratory related costs |
|
|
|
|
|
|
|
977,000
|
215,000
|
|
| Royalty expense |
|
|
|
|
|
|
|
|
0
|
|
| Financing lease payments to third-party |
|
|
|
|
|
|
|
255,000
|
210,000
|
|
| Finance lease, liability |
|
|
|
|
|
|
|
$ 490,000
|
$ 819,000
|
|